Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 912

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

An Official ATS Statement: Hepatotoxicity of Antituberculosis Therapy

Saukkonen, Jussi J., Cohn, David L., Jasmer, Robert M., Schenker, Steven, Jereb, John A., Nolan, Charles M., Peloquin, Charles A., Gordin, Fred M., Nunes, David, Strader, Dorothy B., Bernardo, John, Venkataramanan, Raman, Sterling, Timothy R.·2006·American Journal of Respiratory and Critical Care Medicine
DOI 10.1164/rccm.200510-1666st
Open this paper in CoChat — free account

Abstract

Drug-induced liver injury (DILI) is a problem of increasing significance, but has been a long-standing concern in the treatment of tuberculosis (TB) infection. The liver has a central role in drug metabolism and detoxification, and is consequently vulnerable to injury. The pathogenesis and types of DILI are presented, ranging from hepatic adaptation to hepatocellular injury. Knowledge of the metabolism of anti-TB medications and of the mechanisms of TB DILI is incomplete. Understanding of TB DILI has been hampered by differences in study populations, definitions of hepatotoxicity, and monitoring and reporting practices. Available data regarding the incidence and severity of TB DILI overall, in selected demographic groups, and in those coinfected with HIV or hepatitis B or C virus are presented. Systematic steps for prevention and management of TB DILI are recommended. These include patient and regimen selection to optimize benefits over risks, effective staff and patient education, ready access to care for patients, good communication among providers, and judicious use of clinical and biochemical monitoring. During treatment of latent TB infection (LTBI) alanine aminotransferase (ALT) monitoring is recommended for those who chronically consume alcohol, take concomitant hepatotoxic drugs, have viral hepatitis or other preexisting liver disease or abnormal baseline ALT, have experienced prior isoniazid hepatitis, are pregnant or are within 3 months postpartum. During treatment of TB disease, in addition to these individuals, patients with HIV infection should have ALT monitoring. Some experts recommend biochemical monitoring for those older than 35 years. Treatment should be interrupted and, generally, a modified or alternative regimen used for those with ALT elevation more than three times the upper limit of normal (ULN) in the presence of hepatitis symptoms and/or jaundice, or five times the ULN in the absence of symptoms. Priorities for future studies to develop safer treatments for LTBI and for TB disease are presented.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.200510-1666st

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 174

  1. 2000, Semin Liver Dis, 20, 373, 10.1055/s-2000-9390 · DOI
  2. 2002, Semin Liver Dis, 22, 145, 10.1055/s-2002-30105 · DOI · Paper page
  3. 2002, Ann Intern Med, 137, 947, 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
  4. 1993, Arch Intern Med, 153, 1331, 10.1001/archinte.1993.00410110039007 · DOI
  5. 2002, Semin Liver Dis, 22, 157, 10.1055/s-2002-30103 · DOI
  6. 2004, Clin Infect Dis, 38, S44, 10.1086/381446 · DOI
  7. 1969, Am Rev Respir Dis, 59, 13
  8. 2002, Semin Liver Dis, 22, 137, 10.1055/s-2002-30100 · DOI
  9. 2000, Clin Chem, 46, 2027, 10.1093/clinchem/46.12.2027 · DOI · Paper page
  10. 2000, Clin Chem, 46, 2050, 10.1093/clinchem/46.12.2050 · DOI
  11. 2002, Gastroenterology, 123, 1367, 10.1053/gast.2002.36061 · DOI
  12. 2002, Ann Intern Med, 137, 1
  13. 1999, Br J Clin Pharmacol, 48, 19, 10.1046/j.1365-2125.1999.00952.x · DOI
  14. 2002, Toxicol Pathol, 30, 41, 10.1080/01926230252824699 · DOI
  15. 2003, Chest, 123, 102, 10.1378/chest.123.1.102 · DOI
  16. 1994, Tuber Lung Dis, 75, 58
  17. 1991, Am Rev Respir Dis, 143, 1350, 10.1164/ajrccm/143.6.1350 · DOI
  18. 2000, Immunol Rev, 174, 160, 10.1034/j.1600-0528.2002.017411.x · DOI
  19. 1998, Regul Toxicol Pharmacol, 27, 119, 10.1006/rtph.1998.1201 · DOI
  20. 1989, Arthritis Rheum, 32, 121, 10.1002/anr.1780320202 · DOI
  21. 2002, Rev Gastroenterol Disord, 2, 11
  22. 2003, HIV Clin Trials, 4, 115, 10.1310/N4VT-3E9U-4BKN-CRPW · DOI
  23. 2003, J Acquir Immune Defic Syndr, 33, 146, 10.1097/00126334-200306010-00005 · DOI
  24. 2001, J Gastroenterol Hepatol, 16, 1395, 10.1046/j.1440-1746.2001.02644.x · DOI
  25. 2001, Int J STD AIDS, 12, 555, 10.1258/0956462011923714 · DOI
  26. 2002, Semin Liver Dis, 22, 185, 10.1055/s-2002-30106 · DOI
  27. 1978, Am Rev Respir Dis, 118, 461
  28. 2000, J Clin Pharm Ther, 25, 165, 10.1046/j.1365-2710.2000.00282.x · DOI
  29. 1994, Alcohol Alcohol Suppl, 2, 315
  30. 2001, Tenn Med, 94, 339
  31. 2002, Int J Tuberc Lung Dis, 6, 699
  32. 2003, Clin Infect Dis, 36, 293, 10.1086/345906 · DOI
  33. 2003, J Acquir Immune Defic Syndr, 34, S21, 10.1097/00126334-200309011-00005 · DOI
  34. 2003, Anticancer Drugs, 14, 533, 10.1097/00001813-200308000-00005 · DOI
  35. 1999, Scand J Rheumatol, 28, 273, 10.1080/03009749950155454 · DOI
  36. 1999, J Hepatol, 31, 1098, 10.1016/S0168-8278(99)80326-2 · DOI
  37. 2000, Am J Respir Crit Care Med, 161, S221, 10.1164/ajrccm.161.supplement_3.ats600 · DOI · Paper page
  38. 2005, Eur Respir J, 26, 462, 10.1183/09031936.05.00006205 · DOI
  39. 2002, CMAJ, 167, 131
  40. 1997, Clin Infect Dis, 24, 1264, 10.1093/clinids/24.6.1264 · DOI
  41. 2002, Hepatology, 35, 883, 10.1053/jhep.2002.32102 · DOI
  42. 2003, Hepatology, 37, 924, 10.1053/jhep.2003.50144 · DOI
  43. 1997, J Med Genet, 34, 758, 10.1136/jmg.34.9.758 · DOI
  44. 1975, Clin Pharmacol Ther, 18, 70, 10.1002/cpt197518170 · DOI · Paper page
  45. 1986, Hepatology, 6, 295, 10.1002/hep.1840060223 · DOI
  46. 1981, J Clin Gastroenterol, 3, 271, 10.1097/00004836-198109000-00012 · DOI
  47. 1984, Am Rev Respir Dis, 129, 58
  48. 2001, Indian J Exp Biol, 39, 436
  49. 1996, J Biochem Toxicol, 11, 139, 10.1002/(SICI)1522-7146(1996)11:3<139::AID-JBT6>3.0.CO;2-L · DOI
  50. 1976, Ann Intern Med, 84, 181, 10.7326/0003-4819-84-2-181 · DOI
  51. 2001, Antimicrob Agents Chemother, 45, 382, 10.1128/AAC.45.2.382-392.2001 · DOI
  52. 2000, J Clin Pharm Ther, 25, 165, 10.1046/j.1365-2710.2000.00282.x · DOI
  53. 1997, Br J Clin Pharmacol, 43, 99
  54. 1977, Am Rev Respir Dis, 115, 395
  55. 1986, Am Rev Respir Dis, 133, 1072
  56. 1969, Ann Intern Med, 71, 1113, 10.7326/0003-4819-71-6-1113 · DOI
  57. 1962, Am Rev Respir Dis, 85, 490
  58. 1972, Am Rev Respir Dis, 106, 357, 10.1164/arrd.1972.106.3.357 · DOI
  59. 1979, Am Rev Respir Dis, 117, 991
  60. 1982, Bull World Health Organ, 60, 555
  61. 2003, MMWR Morb Mortal Wkly Rep, 52, 735
  62. 1999, JAMA, 281, 1014, 10.1001/jama.281.11.1014 · DOI · Paper page
  63. 2005, Int J Tuberc Lung Dis, 9, 501
  64. 2005, Chest, 128, 116, 10.1378/chest.128.1.116 · DOI · Paper page
  65. 1996, West J Med, 164, 486491
  66. 1992, Am Rev Respir Dis, 145, 494, 10.1164/ajrccm/145.2_Pt_1.494 · DOI
  67. 1989, Public Health Rep, 104, 151
  68. 1986, JAMA, 256, 2729, 10.1001/jama.1986.03380190099036 · DOI
  69. 1993, Am J Gastroenterol, 88, 590
  70. 2003, Ann Rheum Dis, 62, 1241, 10.1136/ard.2002.004598 · DOI
  71. 1998, Int J Tuberc Lung Dis, 2, 603
  72. 1999, AIDS, 13, 501, 10.1097/00002030-199903110-00009 · DOI
  73. 1986, Am Rev Respir Dis, 134, 666
  74. 2002, Am J Gastroenterol, 97, 1198, 10.1111/j.1572-0241.2002.05704.x · DOI
  75. 2001, Clin Infect Dis, 33, 1687, 10.1086/323896 · DOI
  76. 1983, Rev Infect Dis, 5, S440, 10.1093/clinids/5.Supplement_3.S440 · DOI
  77. 1972, Gut, 13, 366, 10.1136/gut.13.5.366 · DOI
  78. 1971, BMJ, 3, 182
  79. 2001, Int J Clin Pract, 55, 81, 10.1111/j.1742-1241.2001.tb10985.x · DOI
  80. 2004, Am J Respir Crit Care Med, 170, 445, 10.1164/rccm.200404-478OC · DOI
  81. 1992, Am Rev Respir Dis, 145, 36, 10.1164/ajrccm/145.1.36 · DOI · Paper page
  82. 2003, J Chemother, 15, 248, 10.1179/joc.2003.15.3.248 · DOI
  83. 2002, Gut, 50, 436, 10.1136/gut.50.3.436 · DOI · Paper page
  84. 2002, Gastroenterology, 123, 1649, 10.1053/gast.2002.36591 · DOI · Paper page
  85. 1998, Nephrol Dial Transplant, 13, 924, 10.1093/ndt/13.4.924 · DOI
  86. 1999, Medicine, 78, 361, 10.1097/00005792-199911000-00001 · DOI
  87. 1996, Proc Natl Acad Sci USA, 93, 4001, 10.1073/pnas.93.9.4001 · DOI
  88. 2004, J Biol Chem, 279, 38379, 10.1074/jbc.M404949200 · DOI
  89. 2001, J Pharmacol Exp Ther, 299, 849, 10.1016/S0022-3565(24)29202-8 · DOI · Paper page
  90. 2003, Clin Pharmacokinet, 42, 819, 10.2165/00003088-200342090-00003 · DOI
  91. 1974, Lancet, 1, 421
  92. 1996, Am J Respir Crit Care Med, 154, 1473, 10.1164/ajrccm.154.5.8912767 · DOI
  93. 1997, Am J Respir Crit Care Med, 155, 1735, 10.1164/ajrccm.155.5.9154885 · DOI
  94. 2000, Am J Respir Crit Care Med, 162, 989, 10.1164/ajrccm.162.3.9804117 · DOI
  95. 1991, Chest, 99, 465, 10.1378/chest.99.2.465 · DOI · Paper page
  96. 1990, Arzneimittelforschung, 40, 76
  97. 1993, Biochem Pharmacol, 46, 975, 10.1016/0006-2952(93)90661-F · DOI
  98. 1993, Biochem Pharmacol, 46, 2277, 10.1016/0006-2952(93)90618-7 · DOI
  99. 1981, Biochim Biophys Acta, 677, 109, 10.1016/0304-4165(81)90151-3 · DOI
  100. 1987, Anal Biochem, 160, 346, 10.1016/0003-2697(87)90058-3 · DOI
  101. 2003, MMWR Morbid Mortal Wkly Rep, 52, 1
  102. 2001, Biosci Biotechnol Biochem, 65, 1339, 10.1271/bbb.65.1339 · DOI
  103. 2001, MMWR Morb Mortal Wkly Rep, 50, 733
  104. 1997, J Clin Gastroenterol, 24, 264, 10.1097/00004836-199706000-00019 · DOI
  105. 1995, Rev Mal Respir, 12, 314
  106. 1988, Eur Respir J, 1, 807, 10.1183/09031936.93.01090807 · DOI
  107. 2002, MMWR Morb Mortal Wkly Rep, 51, 998
  108. 2000, JAMA, 283, 1445, 10.1001/jama.283.11.1445 · DOI
  109. 2004, Clin Infect Dis, 39, 561, 10.1086/422724 · DOI
  110. 1998, Lancet, 35I, 786
  111. 1998, AIDS, 12, 2447, 10.1097/00002030-199818000-00014 · DOI
  112. 1990, Am Rev Respir Dis, 141, A437
  113. 1991, Am Rev Respir Dis, 143, A119, 10.1164/ajrccm/143.1.119 · DOI
  114. 1994, Pneumologie, 48, 761
  115. 2001, Chest, 119, 833, 10.1378/chest.119.3.833 · DOI
  116. 2002, Ann Intern Med, 137, 640, 10.7326/0003-4819-137-8-200210150-00007 · DOI
  117. 2005, Chest, 127, 1296
  118. 2002, JAMA, 288, 165, 10.1001/jama.288.2.165 · DOI
  119. 2004, Clin Infect Dis, 39, 488, 10.1086/422645 · DOI
  120. 2003, Am J Respir Crit Care Med, 167, 824, 10.1164/rccm.200209-998OC · DOI
  121. 1988, Eur J Clin Pharmacol, 34, 595, 10.1007/BF00615223 · DOI
  122. 1995, Clin Infect Dis, 21, 594, 10.1093/clinids/21.3.594 · DOI
  123. 2000, J Infect Dis, 181, 1289, 10.1086/315380 · DOI
  124. 1996, N Engl J Med, 335, 392, 10.1056/NEJM199608083350604 · DOI · Paper page
  125. 1986, Br Med J (Clin Res Ed), 292, 866, 10.1136/bmj.292.6524.866 · DOI
  126. 2000, Clin Ther, 22, 798, 10.1016/S0149-2918(00)80053-3 · DOI
  127. 1991, Am J Med, 91, 153S, 10.1016/0002-9343(91)90330-Z · DOI
  128. 1989, Rev Infect Dis, 11, S1365, 10.1093/clinids/11.Supplement_5.S1365 · DOI
  129. 2001, Dig Dis Sci, 46, 925, 10.1023/A:1010741510046 · DOI
  130. 1997, Dig Dis Sci, 42, 192, 10.1023/A:1018870029216 · DOI
  131. 2002, Ann Pharmacother, 36, 1162, 10.1345/aph.1A414 · DOI
  132. 2001, Chemotherapy, 47, 32, 10.1159/000057842 · DOI · Paper page
  133. 2004, Clin Ther, 26, 940, 10.1016/S0149-2918(04)90170-1 · DOI
  134. 2001, J Gastroenterol Hepatol, 16, 1028, 10.1046/j.1440-1746.2001.02570.x · DOI
  135. 1996, Tuber Lung Dis, 77, 37, 10.1016/S0962-8479(96)90073-8 · DOI
  136. 2003, Am J Respir Crit Care Med, 167, 1472, 10.1164/rccm.200206-626OC · DOI
  137. 1996, Tuber Lung Dis, 77, 335, 10.1016/S0962-8479(96)90098-2 · DOI
  138. 2002, Int J Tuberc Lung Dis, 6, 699
  139. 1996, Eur Respir J, 9, 2026, 10.1183/09031936.96.09102026 · DOI · Paper page
  140. 1997, J Gastroenterol Hepatol, 12, 87, 10.1111/j.1440-1746.1997.tb00353.x · DOI
  141. 2002, Clin Pharmacol Ther, 72, 220, 10.1067/mcp.2002.126175 · DOI
  142. 1985, Pediatr Infect Dis, 4, 270, 10.1097/00006454-198505000-00013 · DOI
  143. 1986, Tubercle, 67, 99, 10.1016/0041-3879(86)90003-6 · DOI
  144. 1983, Pediatrics, 72, 491, 10.1542/peds.72.4.491 · DOI
  145. 1984, Am Rev Respir Dis, 129, 921
  146. 2004, Ann Pharmacother, 38, 1074, 10.1345/aph.1D525 · DOI
  147. 1990, Ann Intern Med, 112, 407, 10.7326/0003-4819-76-3-112-6-407 · DOI
  148. 1985, Am Rev Respir Dis, 132, 374
  149. 1990, Cent Afr J Med, 36, 104
  150. 1997, J Gastroenterol Hepatol, 12, 87, 10.1111/j.1440-1746.1997.tb00353.x · DOI
  151. 1986, Pediatrics, 77, 912, 10.1542/peds.77.6.912 · DOI
  152. 1996, J Clin Gastroenterol, 22, 211, 10.1097/00004836-199604000-00012 · DOI
  153. 1991, Trop Geogr Med, 43, 156
  154. 2002, Am J Respir Crit Care Med, 166, 916, 10.1164/rccm.2108091 · DOI
  155. 2001, J Gastroenterol Hepatol, 16, 1033, 10.1046/j.1440-1746.2001.02585.x · DOI
  156. 2000, Transplantation, 69, 64, 10.1097/00007890-200001150-00013 · DOI
  157. 1989, Ir Med J, 82, 11
  158. 1980, Tubercle, 61, 41, 10.1016/0041-3879(80)90060-4 · DOI
  159. 1990, Ann Intern Med, 112, 397, 10.7326/0003-4819-76-3-112-6-397 · DOI
  160. 1983, S Afr Med J, 63, 960
  161. 1991, N Engl J Med, 324, 289, 10.1056/NEJM199101313240503 · DOI · Paper page
  162. 1998, Clin Infect Dis, 26, 1148, 10.1086/520275 · DOI
  163. 2005, J Acquir Immune Defic Syndr, 39, 464, 10.1097/01.qai.0000152400.36723.85 · DOI
  164. 1996, Am J Respir Crit Care Med, 154, 1034, 10.1164/ajrccm.154.4.8887603 · DOI
  165. 1998, Am J Respir Crit Care Med, 157, 1871, 10.1164/ajrccm.157.6.9711039 · DOI
  166. 1990, Gastroenterology, 98, 502, 10.1016/0016-5085(90)90846-S · DOI
  167. 2000, Hepatology, 31, 201, 10.1002/hep.510310129 · DOI
  168. 2005, Chest, 127, 1304
  169. 1965, Am Rev Respir Dis, 92, 39
  170. 1963, Am Rev Respir Dis, 87, 896
  171. 1968, Tubercle, 49, 125, 10.1016/0041-3879(68)90017-2 · DOI
  172. 1967, Tubercle, 48, 137, 10.1016/S0041-3879(67)80008-4 · DOI
  173. 1975, Q J Med, XLIV, 1
  174. 2004, Hepatology, 39, 857, 10.1002/hep.20110 · DOI

Cited by

See all 912

Metadata

Authors
Saukkonen, J. J., Cohn, D. L., Jasmer, R. M., Schenker, S., Jereb, J. A., Nolan, C. M., Peloquin, C. A., Gordin, F. M., Nunes, D., Strader, D. B., Bernardo, J., Venkataramanan, R., & Sterling, T. R.
Affiliations
This official statement was approved by the ATS Board of Directors, March 2006
Venue
American Journal of Respiratory and Critical Care Medicine
Publisher
Oxford University Press (OUP)
Published
2006-10
Volume
174
Issue
8
Pages
935-952
ISSN
  • 1073-449X
  • 1535-4970
DOI
10.1164/rccm.200510-1666st
Cited by
912
References
2
Language
en
Licence
academic.oup.com/pages/standard-publication-reuse-rights (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.